Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection

Microbes and Infection

Volumn 8, Issue 14-15, 2006, Pages 2841-2848

  Hu, Dong Liang ^a   Omoe, Katsuhiko ^b   Narita, Kouji ^a   Cui, Jing Chun ^c,d   Shinagawa, Kunihiro ^b   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b IWATE UNIVERSITY   (Japan)

^c DALIAN NATIONALITIES UNIVERSITY   (China)

^d Dalian SEM Bio Engineering Technology Co Ltd   (China)

Author keywords

Enterotoxin; Immune response; Infection; Intranasal vaccination; Staphylococcus aureus; Superantigen; Vaccine

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 4; STAPHYLOCOCCUS ENTEROTOXIN C;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNIZATION; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TITRIMETRY; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; CELLS, CULTURED; ENTEROTOXINS; IMMUNE SERA; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MUTATION; SPLEEN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 33845385112     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.09.001     Document Type: Article

References (29)

1. Foster T.J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3 (2005) 948-958
2. Ferens W.A., Davis W.C., Hamilton M.J., Park Y.H., Deobald C.F., Fox L., and Bohach G. Activation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C. Infect. Immun. 66 (1998) 573-580
3. Fitzgerald J.R., Monday S.R., Foster T.J., Bohach G.A., Hartigan P.J., Meaney W.J., and Smyth C.J. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J. Bacteriol. 183 (2001) 63-70
4. Michie C.A. Staphylococcal vaccines. Trends Immunol. 23 (2002) 461-463
5. Dinges M.M., Orwin P.M., and Schlievert P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13 (2000) 16-34
6. Schlievert P.M. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J. Allergy Clin. Immunol. 108 (2001) S107-S110
7. Edwards V.M., Deringer J.R., Callantine S.D., Deobald C.F., Berger P.H., Kapur V., Stauffacher C.V., and Bohach G.A. Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Infect. Immun. 65 (1997) 2346-2352
8. Fields B.A., Malchiodi E.L., Li H., Ysern X., Stauffacher C.V., Schlievert P.M., Karjalainen K., and Mariuzza R.A. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 384 (1996) 188-192
9. Leder L., Llera A., Lavoie P.M., Lebedeva M.I., Li H., Sekaly R.P., Bohach G.A., Gahr P.J., Schlievert P.M., Karjalainen K., and Mariuzza R.A. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J. Exp. Med. 187 (1998) 823-833
10. Bavari S., Dyas B., and Ulrich R.G. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. J. Infect. Dis. 174 (1996) 338-345
11. Ulrich R.G., Olson M.A., and Bavari S. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 16 (1998) 1857-1864
12. Lowell G.H., Kaminski R.W., Grate S., Hunt R.E., Charney C., Zimmer S., and Colleton C. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect. Immun. 64 (1996) 1706-1713
13. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Fujihashi K., Van Ginkel F.W., Noda M., Takeda Y., and McGhee J.R. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5267-5272
14. De Filette M., Ramne A., Birkett A., Lycke N., Lowenadler B., Min Jou W., Saelens X., and Fiers W. The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine 24 (2006) 544-551
15. Nakane A., Okamoto M., Asano M., Kohanawa M., and Minagawa T. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 63 (1995) 1165-1172
16. Omoe K., Ishikawa M., Shimoda Y., Hu D.L., Ueda S., and Shinagawa K. Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S. aureus isolates harboring seg, seh, or sei genes. J. Clin. Microbiol. 40 (2002) 857-862
17. Hu D.L., Omoe K., Sasaki S., Sashinami H., Sakuraba H., Yokomizo Y., Shinagawa K., and Nakane A. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J. Infect. Dis. 188 (2003) 743-752
18. Gampfer J., Thon V., Gulle H., Wolf H.M., and Eibl M.M. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. Vaccine 20 (2002) 1354-1364
19. Nilsson I.M., Patti J.M., Bremell T., Hook M., and Tarkowski A. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J. Clin. Invest. 101 (1998) 2640-2649
20. Bavari S., Ulrich R.G., and LeClaire R.D. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J. Infect. Dis. 180 (1999) 1365-1369
21. Kum W.W., and Chow A.W. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. J. Infect. Dis. 183 (2001) 1739-1748
22. Florquin S., Amraoui Z., Abramowicz D., and Goldman M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153 (1994) 2618-2623
23. Howard M., Muchamuel T., Andrade S., and Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177 (1993) 1205-1208
24. Hasko G., Virag L., Egnaczyk G., Salzman A.L., and Szabo C. The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B. Eur. J. Immunol. 28 (1998) 1417-1425
25. Sasaki S., Nishikawa S., Miura T., Mizuki M., Yamada K., Madarame H., Tagawa Y.I., Iwakura Y., and Nakane A. Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect. Immun. 68 (2000) 2424-2430
26. Zhao Y.X., and Tarkowski A. Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J. Immunol. 155 (1995) 5736-5742
27. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., Elson C.O., Pillai S., and McGhee J.R. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178 (1993) 1309-1320
28. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., Okahashi N., Yamamoto M., Kiyono H., Bluethmann H., Fujihashi K., and McGhee J.R. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155 (1995) 4621-4629
29. VanCott J.L., Staats H.F., Pascual D.W., Roberts M., Chatfield S.N., Yamamoto M., Coste M., Carter P.B., Kiyono H., and McGhee J.R. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156 (1996) 1504-1514